Skip to main content
. 2020 Oct 9;12(10):950. doi: 10.3390/pharmaceutics12100950

Figure 2.

Figure 2

Isolation, preparation, particle size, and PDI of cell membrane vesicles. (A) Red blood cells (RBCs), (B) LO2, (C) 4T1, and (D) A549/T.

HHS Vulnerability Disclosure